PTK6 and breast carcinoma: If Brk expression is related to differentiation capacity, especially to a keratinocyte-like phenotype, we hypothesised that Brk-positive breast cancer cells may be susceptible to growth inhibition by keratinocyte-differentiating agents such as vitamin D3.